Groupe d'Etude en Oncologie du Quebec

Title	A Randomized Study of Vocal-cord Only vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
Protocole ID	VOCAL
ClinicalTrials.gov ID	NCT03759431
Cancer Type(s)	Head and Neck
Phase	Phase II
Stage
Study Type	Treatment
Drug
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
City	Montréal
Principal Investigator	Dr. Houda Bahig
Coordinator	Diane Trudel 514-890-8000 poste 11181
Status	Recruiting
Activation Date	02-10-2018
Eligibility Criteria	Stage T1a-b N0 of the true vocal cords planned for definitive RT Patient not candidate for laser surgery or declined laser surgery Biopsy-confirmed squamous cell carcinoma, including verrucous carcinoma Eastern Cooperative Oncology Group performance status 0-2 Ability to provide written informed consent.
Exclusion Criteria	Previous irradiation of the head and neck (HNC) region Pregnancy or breastfeeding Any medical condition that represents, in the opinion of the investigator, a contraindication to radiotherapy or would prevent follow-up after radiotherapy. Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 2 years.

Groupe d'étude en oncologie du Québec